已收盤 08-07 16:00:00 美东时间
+8.180
+4.35%
今日重点评级关注:HC Wainwright & Co.:维持Enlivex"买入"评级,目标价从20美元升至80美元;Canaccord Genuity:维持Pharming Group NV Sponsored ADR"买入"评级,目标价从37美元升至38美元
08-04 11:45
B of A Securities analyst Christopher Nardone reinstates RH (NYSE:RH) with a Underperform and announces $156 price target.
08-03 19:16
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often look for circumstances when the market estimation of an option diverges away fro...
07-30 01:35
今日重点评级关注:摩根士丹利:维持TeraWulf"超配"评级,目标价从66.5美元升至72美元;HC Wainwright & Co.:维持Vera Therapeutics"买入"评级,目标价从110美元升至125美元
07-09 12:35
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Evercore ISI Group analyst Stephen Richardson upgraded Occidental Petroleum Corp (NYSE:OXY) from ...
07-08 19:14
Goldman Sachs analyst Kate McShane upgrades RH (NYSE:RH) from Sell to Neutral and raises the price target from $86 to $155.
07-08 17:52
Fresh short‑interest data for late June shows a tightly packed group of mid‑ and large‑cap names where bearish positioning has reached extreme territory, setting the stage for violent moves if sentiment flips. LCID stock is moving. See the chart and price action here. For short sellers, these are h...
06-29 22:35
U.S. stocks were higher, with the Nasdaq Composite gaining more than 50 points on Wednesday. Shares of KB Home (NYSE:KBH) rose sharply after the company reported financial results for the second quarter. KB Home reported second-quarter revenue of $1.11 billion, beating analyst estimates of $1.10 bil...
06-24 21:56
Horizon Quantum Holdings Ltd Class A涨7.53%;Beam Therapeutics涨6.11%;Infleqtion, Inc.涨4.43%
06-23 15:01
今日重点评级关注:HC Wainwright & Co.:维持Elicio Therapeutics"买入"评级,目标价从17美元升至23美元;Leerink Partners:维持SAB Biotherapeutics"跑赢大市"评级,目标价从7美元升至12美元
06-16 11:34